Watts Ryan J.
Insider CIK 1724310 · DNLI President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics Inc. | G Gift | 2026-08-12 | 2026-08-14 | 32,220 | — | $0 | 2,120,384 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2026-08-12 | 2026-08-14 | 32,220 | — | $0 | 2,120,384 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2026-01-06 | 2026-01-08 | 35,198 | $16.50 | $580.8K | 296,833 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2026-01-03 | 2026-01-05 | 236,880 | — | $0 | 236,880 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2026-01-03 | 2026-01-05 | 78,960 | — | $0 | 332,031 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2025-09-03 | 2025-09-05 | 50,000 | — | $0 | 2,152,604 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2025-07-09 | 2025-07-11 | 40,000 | — | $0 | 20,369 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2025-07-09 | 2025-07-11 | 455,282 | — | $0 | 622,809 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2025-07-09 | 2025-07-11 | 455,282 | $0.68 | $309.6K | 708,353 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-07-09 | 2025-07-11 | 495,282 | $15.00 | $7.43M | 253,071 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2025-07-09 | 2025-07-11 | 40,000 | $5.28 | $211.2K | 748,353 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-01-07 | 2025-01-08 | 7,650 | $20.81 | $159.2K | 253,071 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-01-06 | 2025-01-08 | 29,266 | $20.22 | $591.8K | 260,721 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2025-01-03 | 2025-01-07 | 162,540 | — | $0 | 162,540 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2025-01-03 | 2025-01-07 | 54,180 | — | $0 | 289,987 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2024-10-18 | 2024-10-22 | 40,000 | — | $0 | 1,078,091 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-10-18 | 2024-10-22 | 40,000 | $27.69 | $1.11M | 235,807 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2024-10-18 | 2024-10-22 | 40,000 | $0.68 | $27.2K | 275,807 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-08-20 | 2024-08-22 | 2,260 | $23.79 | $53.8K | 235,807 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2024-03-29 | 2024-03-29 | 40,000 | — | $0 | 2,202,604 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-02-13 | 2024-02-15 | 9,589 | $17.29 | $165.8K | 238,067 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-01-09 | 2024-01-11 | 7,818 | $19.78 | $154.6K | 2,268,363 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-01-05 | 2024-01-09 | 17,483 | $19.43 | $339.7K | 2,276,181 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-01-03 | 2024-01-05 | 268,560 | — | $0 | 268,560 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-01-03 | 2024-01-05 | 89,520 | — | $0 | 272,957 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-21 | 2023-08-23 | 2,309 | $22.59 | $52.2K | 2,242,604 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-08-10 | 2023-08-14 | 2,526 | — | $0 | 1,118,091 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-10 | 2023-08-14 | 2,526 | $25.03 | $63.2K | 2,239,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-08-10 | 2023-08-14 | 2,526 | $0.68 | $1.7K | 2,242,439 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-06-16 | 2023-06-20 | 50,000 | — | $0 | 1,120,617 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-06-16 | 2023-06-20 | 50,000 | $31.40 | $1.57M | 2,239,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-06-16 | 2023-06-20 | 50,000 | $0.68 | $34.0K | 2,289,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-04-21 | 2023-04-24 | 24,800 | — | $0 | 1,170,617 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-04-21 | 2023-04-24 | 24,800 | $25.15 | $623.7K | 2,239,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-04-21 | 2023-04-24 | 24,800 | $0.68 | $16.9K | 2,264,713 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-04-20 | 2023-04-24 | 200 | — | $0 | 1,195,417 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-04-20 | 2023-04-24 | 200 | $0.68 | $136 | 2,240,113 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-04-20 | 2023-04-24 | 200 | $25.00 | $5.0K | 2,239,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-02-13 | 2023-02-15 | 25,000 | — | $0 | 1,195,617 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-13 | 2023-02-15 | 8,815 | $30.09 | $265.2K | 2,239,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-13 | 2023-02-15 | 25,000 | $30.08 | $752.0K | 2,239,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-02-13 | 2023-02-15 | 25,000 | $0.68 | $17.0K | 2,264,913 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2023-02-10 | 2023-02-13 | 25,000 | — | $0 | 1,220,617 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-10 | 2023-02-13 | 25,000 | $29.10 | $727.5K | 2,229,031 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2023-02-10 | 2023-02-13 | 25,000 | $0.68 | $17.0K | 2,254,031 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-09 | 2023-02-13 | 3,433 | $30.59 | $105.0K | 2,229,031 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-05 | 2023-01-09 | 4,800 | $28.44 | $136.5K | 2,223,664 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-04 | 2023-01-05 | 5,029 | $28.73 | $144.5K | 2,213,464 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 246,720 | — | $0 | 246,720 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-01-03 | 2023-01-05 | 82,240 | — | $0 | 231,934 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-08-19 | 2022-08-23 | 2,404 | $33.22 | $79.9K | 2,202,993 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-02-11 | 2022-02-15 | 9,491 | $34.72 | $329.5K | 2,129,648 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2022-02-10 | 2022-02-11 | 6,118 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2022-02-10 | 2022-02-11 | 64,631 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2022-02-10 | 2022-02-11 | 64,631 | $5.28 | $341.3K | 254,522 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2022-02-10 | 2022-02-11 | 6,118 | $9.60 | $58.7K | 260,640 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-02-09 | 2022-02-11 | 2,719 | $37.55 | $102.1K | 2,119,442 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-01-05 | 2022-01-07 | 5,007 | $44.78 | $224.2K | 2,113,361 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 186,500 | — | $0 | 186,500 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-01-03 | 2022-01-05 | 62,000 | — | $0 | 213,691 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-01 | 2021-12-03 | 805 | $46.35 | $37.3K | 2,103,368 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-01 | 2021-12-03 | 9,012 | $45.30 | $408.2K | 2,104,173 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-01 | 2021-12-03 | 8,516 | $44.39 | $378.0K | 2,113,185 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-11-01 | 2021-11-03 | 1,659 | $48.61 | $80.6K | 2,138,375 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-11-01 | 2021-11-03 | 16,674 | $49.87 | $831.5K | 2,121,701 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-10-01 | 2021-10-05 | 4,247 | $50.99 | $216.6K | 2,140,034 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-10-01 | 2021-10-05 | 3,304 | $49.38 | $163.2K | 2,155,063 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-10-01 | 2021-10-05 | 10,782 | $50.44 | $543.8K | 2,144,281 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-03 | 7,441 | $54.27 | $403.8K | 2,169,259 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-03 | 10,892 | $54.92 | $598.2K | 2,158,367 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-19 | 2021-08-23 | 1,626 | $49.38 | $80.3K | 2,177,450 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-19 | 2021-08-23 | 750 | $49.97 | $37.5K | 2,176,700 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-02 | 2021-08-04 | 8,543 | $50.80 | $434.0K | 2,183,866 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-02 | 2021-08-04 | 9,790 | $51.94 | $508.5K | 2,174,076 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-07-01 | 2021-07-06 | 3,030 | $76.38 | $231.4K | 2,207,712 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-07-01 | 2021-07-06 | 2,459 | $77.84 | $191.4K | 2,192,409 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-07-01 | 2021-07-06 | 12,844 | $77.35 | $993.5K | 2,194,868 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-01 | 2021-06-03 | 2,750 | $62.09 | $170.7K | 2,213,198 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-01 | 2021-06-03 | 13,127 | $60.98 | $800.5K | 2,215,948 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-01 | 2021-06-03 | 2,102 | $62.76 | $131.9K | 2,211,096 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-01 | 2021-06-03 | 354 | $63.50 | $22.5K | 2,210,742 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-03 | 2021-05-05 | 3,485 | $59.12 | $206.0K | 2,229,926 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-03 | 2021-05-05 | 13,997 | $58.45 | $818.1K | 2,233,411 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-03 | 2021-05-05 | 851 | $59.92 | $51.0K | 2,229,075 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-01 | 2021-04-05 | 8,516 | $56.88 | $484.4K | 2,251,994 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-01 | 2021-04-05 | 5,232 | $55.52 | $290.5K | 2,260,510 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-01 | 2021-04-05 | 4,586 | $57.31 | $262.8K | 2,247,408 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2021-03-09 | 2021-04-05 | 40,000 | — | $0 | 2,265,742 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 1,625 | $68.46 | $111.2K | 2,306,404 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 594 | $69.65 | $41.4K | 2,305,810 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 3,339 | $67.69 | $226.0K | 2,308,029 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 68 | $70.92 | $4.8K | 2,305,742 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 3,370 | $64.42 | $217.1K | 2,320,706 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 5,885 | $65.63 | $386.2K | 2,314,821 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 3,453 | $66.55 | $229.8K | 2,311,368 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-11 | 2021-02-16 | 960 | $71.47 | $68.6K | 2,324,076 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-11 | 2021-02-16 | 8,513 | $70.17 | $597.4K | 2,325,036 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-09 | 2021-02-10 | 1,634 | $74.05 | $121.0K | 2,314,664 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-09 | 2021-02-10 | 811 | $75.07 | $60.9K | 2,313,853 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-09 | 2021-02-10 | 2,667 | $73.24 | $195.3K | 2,316,298 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-02-08 | 2021-02-10 | 8,800 | — | $0 | 17,600 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-02-08 | 2021-02-10 | 5,516 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-02-08 | 2021-02-10 | 5,516 | — | $0 | 2,310,165 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-02-08 | 2021-02-10 | 8,800 | — | $0 | 2,318,965 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-01 | 2021-02-02 | 3,552 | $69.17 | $245.7K | 2,305,209 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-01 | 2021-02-02 | 560 | $69.69 | $39.0K | 2,304,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-01 | 2021-02-02 | 14,222 | $68.21 | $970.1K | 2,308,761 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 180,000 | — | $0 | 180,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,224 | $68.26 | $83.6K | 2,407,088 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,142 | $84.24 | $96.2K | 2,322,978 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,300 | $65.21 | $84.8K | 2,410,012 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,700 | $66.63 | $113.3K | 2,408,312 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,225 | $83.43 | $102.2K | 2,324,120 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 9,900 | $70.02 | $693.2K | 2,397,188 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 11,896 | $70.82 | $842.5K | 2,385,292 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 8,683 | $71.77 | $623.2K | 2,376,609 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 9,443 | $72.63 | $685.8K | 2,367,166 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 7,322 | $73.78 | $540.2K | 2,359,844 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,100 | $74.52 | $82.0K | 2,358,744 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,620 | $76.07 | $123.2K | 2,357,124 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 7,410 | $82.44 | $610.9K | 2,325,345 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 7,539 | $81.66 | $615.6K | 2,332,755 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,400 | $80.25 | $112.3K | 2,340,294 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 4,208 | $79.57 | $334.8K | 2,341,694 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 9,482 | $78.41 | $743.5K | 2,345,902 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-06 | 1,740 | $77.29 | $134.5K | 2,355,384 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-08-18 | 2020-08-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2020-06-18 | 2020-06-18 | 40,000 | — | $0 | 2,389,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-03-30 | 2020-04-01 | 4,807 | $19.48 | $93.6K | 22,013 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-02-10 | 2020-02-12 | 367,675 | — | $0 | 367,675 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-02-10 | 2020-02-12 | 78,787 | — | $0 | 78,787 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2020-02-08 | 2020-04-01 | 5,515 | — | $0 | 5,516 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2020-02-08 | 2020-04-01 | 8,800 | — | $0 | 26,400 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2020-02-08 | 2020-04-01 | 5,515 | — | $0 | 18,020 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2020-02-08 | 2020-04-01 | 8,800 | — | $0 | 26,820 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-12-04 | 2019-12-05 | 18,755 | $18.00 | $337.6K | 2,429,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-12-03 | 2019-12-05 | 2,513 | $18.02 | $45.3K | 2,448,059 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-11-25 | 2019-11-26 | 42,185 | $18.02 | $760.2K | 2,450,572 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-11-22 | 2019-11-26 | 1,300 | $18.00 | $23.4K | 2,492,757 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-09-05 | 2019-09-05 | 4,847 | $18.09 | $87.7K | 2,494,057 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-09-03 | 2019-09-05 | 3,734 | $18.00 | $67.2K | 2,498,904 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-07-01 | 2019-07-03 | 18,333 | $20.76 | $380.6K | 2,502,638 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-06-03 | 2019-06-05 | 18,333 | $19.07 | $349.6K | 2,560,971 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2019-05-14 | 2019-07-03 | 40,000 | — | $0 | 2,520,971 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-05-03 | 2019-05-03 | 6,111 | $24.49 | $149.7K | 2,579,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-05-02 | 2019-05-03 | 6,111 | $24.03 | $146.8K | 2,585,415 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-05-01 | 2019-05-03 | 6,112 | $24.09 | $147.2K | 2,591,526 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-03 | 2019-04-03 | 500 | $26.77 | $13.4K | 2,597,638 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-03 | 2019-04-03 | 5,641 | $26.28 | $148.2K | 2,598,138 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-02 | 2019-04-03 | 2,942 | $25.17 | $74.1K | 2,603,779 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-02 | 2019-04-03 | 3,200 | $24.52 | $78.5K | 2,606,721 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-04-01 | 2019-04-03 | 6,050 | $23.91 | $144.7K | 2,609,921 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-05 | 2019-03-05 | 6,141 | $21.97 | $134.9K | 2,615,971 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-04 | 2019-03-05 | 4,442 | $21.87 | $97.1K | 2,623,812 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-04 | 2019-03-05 | 1,700 | $22.83 | $38.8K | 2,622,112 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-01 | 2019-03-05 | 4,000 | $22.19 | $88.8K | 2,630,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-03-01 | 2019-03-05 | 2,050 | $22.91 | $47.0K | 2,628,254 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-02-08 | 2019-02-11 | 281,600 | — | $0 | 281,600 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-02-08 | 2019-02-11 | 35,200 | — | $0 | 35,200 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-02-08 | 2019-02-11 | 11,031 | — | $0 | 11,031 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-05 | 2019-02-05 | 8,230 | $18.83 | $155.0K | 2,634,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-04 | 2019-02-05 | 854 | $19.12 | $16.3K | 2,642,534 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-04 | 2019-02-05 | 3,200 | $18.49 | $59.2K | 2,643,388 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-02-01 | 2019-02-05 | 6,050 | $18.65 | $112.8K | 2,646,588 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-04 | 2019-01-04 | 1,300 | $19.18 | $24.9K | 2,657,571 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-04 | 2019-01-04 | 4,933 | $20.02 | $98.8K | 2,652,638 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-03 | 2019-01-04 | 6,050 | $18.89 | $114.3K | 2,658,871 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-02 | 2019-01-04 | 5,050 | $19.42 | $98.1K | 2,665,921 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2019-01-02 | 2019-01-04 | 1,000 | $20.24 | $20.2K | 2,664,921 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-12-03 | 2018-12-06 | 400 | $19.16 | $7.7K | 2,670,971 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-12-03 | 2018-12-06 | 17,933 | $18.42 | $330.3K | 2,671,371 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2018-11-27 | 2018-12-06 | 40,000 | — | $0 | 2,689,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-11-15 | 2018-11-15 | 13,588 | $18.12 | $246.2K | 2,729,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-11-13 | 2018-11-15 | 4,746 | $18.00 | $85.4K | 2,742,892 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-10-01 | 2018-10-03 | 18,333 | $21.72 | $398.2K | 2,747,638 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-09-04 | 2018-09-06 | 18,333 | $19.06 | $349.4K | 2,765,971 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2018-08-29 | 2018-08-31 | 18,334 | $18.05 | $330.9K | 2,784,304 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-02-26 | 2018-02-28 | 300,000 | — | $0 | 300,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2017-12-13 | 2018-02-28 | 5 | $20.47 | $102 | 12,505 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-12 | 12,500 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-12 | 12,500 | — | $0 | 12,500 | SEC↗ |